Skip to search formSkip to main contentSkip to account menu

bleomycin/cyclophosphamide/doxorubicin/methotrexate/prednisone/vincristine

Known as: BLEO/CTX/DOX/MTX/PRED/VCR, MACOP-B 
National Institutes of Health

Related topics

Related topics

7 relations
BleomycinCyclophosphamideDoxorubicinDoxorubicin Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
[Long-term results with MACOP-B and radiation therapy for aggressive lymphomas].
BACKGROUND Long-term results are needed to evaluate chemotherapy regimens and prognostic factors in non-Hodgkin's lymphomas (NHL… 
1998
1998
Diagnosis and treatment of malignant lymphoma of the parotid gland.
BACKGROUND To correlate the imaging and pathological features and to discuss therapeutic modalities and the prognosis of… 
1997
1997
BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front‐line therapy for high‐risk patients with diffuse large cell lymphoma
In two consecutive and unselected cohorts of diffuse large cell lymphoma (DLCL) patients with advanced stage disease (IIB or bulk… 
1997
1997
Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group.
BACKGROUND The initial publication of the results of the Australian and New Zealand Lymphoma Group (ANZLG) randomized controlled… 
1995
1995
Anaplastic large cell lymphoma (CD30+/Ki-1+). Analysis of 35 cases followed at GISL centres.
1994
1994
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
PURPOSE The aim of our study was to compare in a multicentric randomized trial two regimens widely used in the treatment of… 
1993
1993
MACOP‐B ± radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford Results According to Prognostic Indices
Background. The efficacy and toxicity of the MACOP‐B regimen were assessed after outstanding results were reported in diffuse… 
1993
1993
A Case of Cutaneous B‐cell Lymphoma Treated Successfully with MACOP‐B
A case of cutaneous B‐cell lymphoma successfully treated by MACOP‐B therapy is described. The patient was a 43‐year‐old man with… 
1989
1989
MACOP-B treatment for advanced stage diffuse large cell lymphoma: a multicenter Italian Study.
Highly Cited
1988
Highly Cited
1988
MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations.
Between 1981 and 1986, we treated 179 newly diagnosed patients with advanced-stage malignant lymphoma or related conditions with… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)